The ATLAS Project is a multinational clinical trial network across nine Asian countries, led by the National Cancer Center Hospital, Japan.<\/p>\r\n
Under Japan\u2019s leadership, multiple international collaborative clinical trials are conducted in parallel, aiming to accelerate regulatory approval and practical implementation of pharmaceuticals and medical devices throughout Asia.<\/p>\r\n
Pharmaceutical and medical device companies can implement their development products as investigator-initiated clinical trials through the ATLAS network.<\/p>\r\n
Clinical trials can include not only Asian sites, but also participating institutions in the United States, Europe, and other regions.<\/p>\r\n
MASTER KEY Asia can be used to screen patients based on biomarkers.
\r\nPatients who test positive can then be enrolled into company-sponsored clinical trials.<\/p>\r\n
The ATLAS network can be utilized for company-sponsored trials across Asia, including the implementation of decentralized clinical trials (DCTs).<\/p>\r\n